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Abstract: There is currently a huge need for new, improved therapeutic approaches for the treatment
of chronic wounds. One promising strategy is to develop wound dressings capable of modulating
the chronic wound environment (e.g., by controlling the high levels of reactive oxygen species (ROS)
and proteases). Here, we selected the thiol-containing amino acid cysteine to endow wood-derived
cellulose nanofibrils (CNF) with bioactivity toward the modulation of ROS levels and protease activity.
Cysteine was covalently incorporated into CNF and the functionalized material, herein referred as
cys-CNF, was characterized in terms of chemical structure, degree of substitution, radical scavenging
capacity, and inhibition of protease activity. The stability of the thiol groups was evaluated over time,
and an in vitro cytotoxicity study with human dermal fibroblasts was performed to evaluate the
safety profile of cys-CNF. Results showed that cys-CNF was able to efficiently control the activity of
the metalloprotease collagenase and to inhibit the free radical DPPH (1,1-Diphenyl-2-picrylhydrazyl
radical), activities that were correlated with the presence of free thiol groups on the nanofibers. The
stability study showed that the reactivity of the thiol groups challenged the bioactivity over time.
Nevertheless, preparing the material as an aerogel and storing it in an inert atmosphere were shown
to be valid approaches to increase the stability of the thiol groups in cys-CNF. No signs of toxicity were
observed on the dermal fibroblasts when exposed to cys-CNF (concentration range 0.1–0.5 mg/mL).
The present work highlights cys-CNF as a promising novel material for the development of bioactive
wound dressings for the treatment of chronic wounds.
Keywords: nanocellulose; wound healing; proteases; reactive oxygen species; cysteine; antioxi-
dant properties
1. Introduction
Cutaneous wound healing is a well-orchestrated process consisting of four overlap-
ping phases: hemostasis, inflammation, proliferation, and remodeling. Most skin wounds
heal within 2–3 weeks, however, imbalances in the wound healing phases can lead to non-
healing chronic wounds [1]. Chronic wounds remain in the inflammatory phase, where
elevated levels of reactive oxygen species (ROS), pro-inflammatory cytokines, and degrada-
tive proteases result in reduced concentrations of growth factors and proteinase inhibitors,
and an imbalance in the wound equilibrium [2]. Diabetes and vascular insufficiency are the
main underlying causes of non-healing wounds, with systemic factors such as advanced
age or a compromised immune system also contributing to poor wound-healing. The
incidence of chronic wounds has dramatically increased in recent years, now reaching
epidemic proportions [3]. Presently, most of the widely used wound dressings only provide
an optimal local healing milieu (i.e., they protect the wound from further trauma, provide
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moisture, and adsorb excess exudate) [4]. To improve the treatment of chronic wounds, it
has been proposed that new types of wound-healing therapies will be required, with the
aim of obtaining bioactive dressings that stimulate local cells to migrate and proliferate,
stimulate, and guide extracellular matrix deposition, modulate protease activity, and/or
neutralize free radicals [4].
Nanocellulose is emerging as an interesting material for biomedical applications such
as tissue engineering, drug delivery, and wound care [5,6]. Nanocellulose consists of
cellulose fibrils or crystallites with dimensions in the nanoscale and is obtained from a
diversity of sources such as wood, algae, bacteria, and tunicates [7]. Wood-derived cellulose
nanofibrils (CNF) comprise individual fibrils that are 2–10 nm in diameter and several
micrometers in length, typically forming 20–60 nm thick aggregates [8]. Characteristics
such as being a renewable material, not being of animal origin, having tuneable properties
in terms of surface chemistry, aspect ratio and form, and being produced in a process that
can easily be scaled-up industrially have contributed to the increased interest in using CNF
for biomedical applications [5,9]. CNF have been described as a promising material for the
treatment of wounds [5,10,11]. Authors have highlighted the physicochemical properties of
the material and the absence of cytotoxicity as beneficial characteristics for employing CNF
films, aerogels, and gel suspensions as wound dressings [12–14]. Moreover, clinical studies
have shown encouraging results when using CNF films on skin graft donor sites [15,16].
Our group has demonstrated the in vitro and in vivo wound healing properties of an
ion-crosslinked CNF hydrogel [17–19] together with the evaluation of its antibacterial
properties [20] and the possibility of using the hydrogel as a drug delivery dressing [21].
In the present work, we selected the amino acid cysteine as an active molecule to
endow CNF with bioactivity and for the first time investigate the potential of the function-
alized CNF material to modulate the chronic wound environment in vitro. It is believed
that addressing the biochemical imbalances typically found in chronic wounds will aid in
the resolution of these hard-to-heal wounds. Thus, by targeting the excess of ROS and the
high level of metalloprotease activity, it may be possible to restore basal levels of growth
factors, promote the restitution of the proper balance between degradation and formation
of new tissue, and help overcome the prolonged inflammatory phase observed in chronic
wounds [22,23]. The radical scavenging properties of cysteine and its metal chelating
ability [24,25], make this amino acid an excellent candidate molecule to be used in the
development of wound dressings capable of interacting with the biochemical environment
of chronic wounds.
In this study, cysteine was covalently incorporated into CNF and the functionalized
material was characterized in terms of chemical structure and degree of substitution. The
radical scavenging properties and the capacity of the material to inhibit metalloprotease
activity were investigated. Furthermore, the stability of the thiol groups in cys-CNF and its
bioactivity were evaluated over time. Finally, the safety profile of the thiol-functionalized
CNF was investigated in an in vitro cytotoxicity study with human dermal fibroblasts.
2. Materials and Methods
2.1. Chemicals and Reagents
Carboxylated-CNF, provided by RISE Bioeconomy (Stockholm, Sweden), was pro-
duced from commercial never-dried bleached sulfite softwood dissolving pulp (lignin
content < 1.5%, xylose < 1.7%, mannose < 1.8%, Domsjö Fabriker AB, Örnsköldsvik,
Sweden) by 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO)-mediated oxidation. L-cysteine
methyl ester hydrochloride, N-(3-dimethyolaminopropyl)-N′-ethylcarbodiimide hydrochlo-
ride (EDC), N-hydroxysuccinimide (NHS), collagenase from Clostridium histolyticum, and
calcein-AM were obtained from Sigma Aldrich (St. Louis, MO, USA). Fetal bovine serum
(FBS), penicillinin, streptomycin, 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB), EnzChek™
Gelatinase/Collagenase Assay Kit, Pierce TM Bradford Protein Assay Kit, DMEM:F12
medium, fetal bovine serum, and presto blue cell viability reagent were obtained from Ther-
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moFisher Scientific (Waltham, MA, USA). 1,1-Diphenyl-2-picrylhydrazyl radical (DPPH)
was purchased from Santa Cruz Biotechnology (Dallas, TX, USA).
2.2. Covalent Incorporation of Methyl Cysteine to Cellulose Nanofibrils
L-cysteine methyl ester was covalently incorporated to carboxylated CNF (c-CNF,
carboxyl group content 1300 µmol/g dry CNF) via EDC/NHS coupling (Figure 1). Briefly,
100 g of c-CNF suspension corresponding to 1 g of dried cellulose was dispersed in 50 mL
of deionized water and 5 mL of aqueous solution containing 180 mg of NHS and 290 mg
of EDC (corresponding to 1.2 mmol of NHS/EDC per mol of carboxyl group in CNF)
were added under stirring, followed by the addition of 10 mL of L-cysteine methyl ester
aqueous solution. Two different molar ratios cysteine:COOH were used in the synthesis,
corresponding to 6 and 20 equivalents of cysteine with respect to the carboxyl groups
in c-CNF. The reaction mixture was stirred for 24 h at pH 5 and room temperature. For
purification, three cycles of centrifugation (30 min at 3380× g) were carried out, followed
by dialysis against deionized water until the conductivity in water was < 0.005 mS/cm2.
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2.3. Material Characterization
2.3.1. Characterization of the Molecular Structure
The chemical structure of cys-CNF was characterized by solid-state nuclear magnetic res-
onance (NMR). The NMR spectra were obtained on a Bruker Avance III 600 MHz spectrometer
(Bruker, Billerica, MA, USA) using a double-resonance 4 mm (1H&19F)/(15N-31P) CP-MAS
probe and 4 mm ZrO2 rotors. The 13C cross-polarization (CP) magic angle spinning (MAS)
NMR spectra were recorded at a spinning frequency of 12 KHz, a contact time of 1–2 ms
and a repetition delay of 3–5 s. The experiments were performed at 298 K.
2.3.2. Degree of Substitution
The cysteine content of cys-CNF was determined by elemental analysis of total sulfur
content. For this, cys-CNF freeze-dried samples were submitted to MEDAC Ltd., analytical
and chemical consultancy services (Cobham, UK), where a Thermo FlashEAR 1112 instru-
ment was used for sulfur q antification. The weight percentage of sulfur in cys-CNF was
converted to mmol cysteine/g CNF [26] and the degree of substitution (DS) was calculated
as the cysteine content (mmol/g CNF) per number of carboxyl groups in th starting
material c-CNF (1.3 mmol/g CNF).
2.3.3. Thiol Group Content
The t i l group content was quantified by the Ellman assay. Briefly, 2.5 mL of reaction
buffer (0.1 M sodium phosphate, pH 8.0, containing 1 mM EDTA) was mixed with 250 µL of
cys-CNF suspension (0.05 wt%) and 50 µL of DTNB solution (4 mg/mL in reaction buffer).
After 15 min, the absorbance at 412 nm was measured using a spectrophotometer (UV-1800,
Shimadzu, Kyoto, Japan). The number of thiol groups in the CNF samples was calculated
using a L-cysteine methyl ester standard curve and expressed as mmol SH/g CNF.
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2.4. Radical Scavenging Capacity
Free radical scavenging capacity was evaluated with DPPH by measuring the decrease
in absorbance of the radical at 517 nm after incubation with the CNF materials. In brief,
1.2 mL of CNF suspension in water (containing 0.5 mg, 2 mg, and 5 mg of dry CNF
materials) was mixed with 10.8 mL of DPPH (0.2 mM in methanol). After 90 min incubation
time protected from direct light, reaction tubes were centrifuged to spin down the CNF
materials and the absorbance of the supernatant was measured at 517 nm with a plate
reader (TECAN infinite M200, Männedorf, Switzerland). Radical scavenging capacity was
expressed as percentage of DPPH inhibition according to Equation (1):






where AS is the absorbance at 517 nm of the DPPH solution after incubation with the CNF sam-
ples and AR is the absorbance at 517 nm of the DPPH reference solution (i.e., incubated alone).
2.5. Evaluation of the Material Interactions with the Metalloprotease Collagenase
Collagenase from Clostridium histolyticum was selected as a model protein to inves-
tigate the interaction of cys-CNF with metalloproteases. Aqueous suspensions (0.7 mL)
of the CNF materials containing 0.1 mg, 0.2 mg, and 3.5 mg of dry cellulose were mixed
with collagenase in reaction buffer (0.5 M Tris-HCl, 1.5 M NaCl, 50 mM CaCl2, and 2 mM
sodium azide, pH 7.6) at a final protein concentration of 10 µg/mL in a final volume of
1.5 mL. The mixture was incubated for 24 h at 37 ◦C under agitation (400 rpm). Afterward,
reaction tubes were centrifuged to spin down the fibers and the supernatant was collected
to determine the collagenase activity and concentration.
2.5.1. Evaluation of Protease Inhibition
The EnzChekTM Collagenase Assay Kit was used to quantify the activity of collage-
nase after incubation with the materials. The assay was performed as indicated by the
manufacturer. Briefly, 20 µL of fluorescein conjugate-gelatin (DQTM Gelatin, 0.5 mg/mL)
was added to 100 µL of reaction buffer (0.5 M Tris-HCl, 1.5 M NaCl, 50 mM CaCl2, and
2 mM sodium azide, pH 7.6) mixed with 80 µL of CNF-incubated collagenase solution.
The increase in fluorescence signal (excitation/emission at 485/530 nm), as a result of
substrate cleavage by the collagenase, was measured from minute 0 to 120 with a plate
reader (TECAN infinite M200, Männedorf, Switzerland). To calculate the inhibition of
collagenase activity, the 30 min time point was selected and the fluorescence intensity of
the CNF-incubated collagenase samples was compared to the fluorescence intensity of the
collagenase control according to Equation (2):







where F is fluorescence intensity (a.u.) at the 30 min time point.
2.5.2. Evaluation of Protease Entrapment
The Bradford assay was used for protein quantification. Simply, 100 µL of CNF-
incubated collagenase was mixed with 100 µL of Bradford reagent in a transparent 96 well
plate. Following the protocol from the manufacturer, the plate was shacked for 30 s and,
after 10 min incubation at room temperature, absorbance was measured at 595 nm with
a plate reader (TECAN infinite M200, Männedorf, Switzerland). Protein entrapment was
expressed as percentage of collagenase in solution after incubation with CNF over the
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where AS and AR are the absorbance values at 595 nm of the sample and of the control
solution, respectively.
2.5.3. Zn2+ Binding Assay
With similar conditions as in the collagenase inhibition experiment, water suspension
of the CNF materials (5 mg dry content) were mixed and incubated with 0.1 mM zinc
acetate in a final volume of 3 mL. The mixture was left in a shaking plate at 37 ◦C for
24 h. Then, fibers were spun down and the zincon assay was performed to quantify the
remaining zinc in the supernatant. Briefly, 25 µL of sample (supernatant) was mixed with
950 µL of 53 mM borate buffer, pH 9; and 25 µL of 1.6 mM zincon (2-carboxy-2′-hydroxy-
5′-sulfoformazyl-benzene) solution were added to the mixture. The absorbance at 620 nm
was measured 5 min later. Zinc content was expressed as a percentage of the reference
solution (i.e., where the CNF suspension was replaced by water).
2.6. Material Stability over Time
The thiol content and the radical scavenging properties of the cys-CNF suspension
were measured by the Ellman assay and the DPPH assay, respectively, over a time period
of 30 days to evaluate the stability of the thiol group in the cys-CNF suspension and the
correlation to its radical scavenging capacity. The material was kept at 4 ◦C in three different
storage conditions: suspensions in a closed container, aerogels prepared by freeze-drying,
and suspensions stored under an inert atmosphere. The Ellman assay and the DPPH assay
were conducted following the protocols described in Sections 2.3 and 2.4, respectively.
2.7. Cell Studies
2.7.1. Cell Culture
Adult human dermal fibroblasts (hDF) (primary cells from the European Collection
of Authenticated Cell Cultures (ECACC, Salisbury, England) were cultured in DMEM-
F12 medium supplemented with 10% v/v fetal bovine serum, 100 U/mL penicillin, and
100 µg/mL streptomycin. Cells were cultured at 37 ◦C and 5% CO2 in a humidified
atmosphere and passaged at 80% confluency.
2.7.2. Cytotoxicity Assessment
The cytotoxicity of cys-CNF was assessed by exposing hDF monolayers to suspensions
of cys-CNF (1:20). Concentrations from 0.1 to 1 mg/mL in cell culture medium were
prepared from 10 mg/mL stock suspension in water the day of the experiment. A control
experiment showed that the dilution of cell culture medium due to the water content of the
CNF stock suspension did not significantly affect the cell viability.
hDF cells (passage numbers 10–16) were seeded in a 96 well-plate at a density of
4.8 × 103 cells/well and after 24 h of culture, they were exposed to the cys-CNF suspensions
(200 µL/well) and cultured for another 24 h. Non-treated cells were used as the negative
control and cells exposed to 5% DMSO in cell culture medium were the positive control.
c-CNF was also included in the toxicity assessment in the same concentration range
as cys-CNF.
Cellular metabolic activity was measured with the presto blue (PB) assay after 24 h
of exposure to the CNF materials. Cell culture media were removed from the cell culture
wells and cells were carefully washed with warm PBS. Thereafter, 200 µL of PB reagent
diluted 1:10 in cell culture media were added to each well and incubated for 90 min at 37 ◦C,
and 5% CO2 in a humidified atmosphere. Aliquots of 100 µL were transferred to a black
96-well plate and fluorescence was measured at 560 nm excitation and 590 nm emission
wavelengths using a plate reader (Tecan infinite M200, Männedorf, Switzerland). Cell
metabolic activity was used as an indicator of cell viability and the results were expressed
as the percentage of the negative control. The interaction of the CNF samples with the PB
reagent was evaluated by applying the same protocol as above, but in the absence of cells
and the results showed no interference of the samples with the PB assay.
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Cell viability and morphology were also assessed by microscopic observations of
calcein-AM stained cells. Briefly, cell media were removed from the wells, and 100 µL of
calcein-AM (0.1% v/v in PBS) were added to each well. After 15 min incubation time in the
cell incubator, cells were imaged with a fluorescence microscope (Nikon Eclipse TE2000-U,
Tokyo, Japan).
2.8. Statistical Analysis
All data are presented as mean ± standard error of the mean from at least three inde-
pendent experiments, each with triplicate sampling. Statistical analyses were performed
using GraphPad Prism software. Differences between groups were evaluated by one-way
analysis of variance (ANOVA), followed by Dunnett’s test for pairwise comparisons. A
t-test was used for paired comparison of the two treatment groups. The differences were
considered statistically significant when the p value was < 0.05.
3. Results and Discussion
3.1. Material Characterization
The broad spectrum of possible chemical modifications of cellulose opens up the
possibility of endowing the material with novel properties. Typically, surface chemical
modifications of cellulose are employed during the production of CNF to introduce charged
groups and facilitate the defibrillation process. Furthermore, post-production chemical
modifications of CNF can take advantage of these introduced charged groups to explore
new functionalization and obtain CNF materials with added value [27]. In the present
work, we investigated the possibility of obtaining a bioactive CNF material by thiol-
functionalization of the fibrils, with the ultimate aim of modulating the high levels of
ROS and metalloproteinases found in hard-to-heal wounds. The carboxyl groups in the
starting CNF, introduced by TEMPO-oxidation pretreatment of the wood pulp, were
targeted to react with the amine groups of the thiol-amino acid cysteine via the EDC/NHS-
mediated coupling.
The covalent incorporation of cysteine to CNF was investigated by CP/MAS 13C-
NMR spectroscopy. The 13C-NMR spectrum of cys-CNF is displayed in Figure 2, together
with the spectrum of c-CNF, cysteine, and cystine (cysteine oxidized dimer) as references.
The signals at 24 ppm in the cys-CNF spectrum could be attributed to the Cβ in cysteine
while the signals around 37 and 43 ppm were assigned to the methylene groups in cystine.
The signals from the Cα and OMe carbons in cysteine and cystine were found to merge
around 54 ppm. The broadening of the signals from cysteine and cystine in cys-CNF
indicates that these two compounds interacted with c-CNF, reducing the motions of the
carbons. Close inspection of the 170–180 ppm region showed a broad shoulder upfield to
the signal of the carboxyl resonance of CNF. This was tentatively assigned to the carbonyl
of the ester in cysteine and cystine and to the amide linkages formed between the amino
acid and c-CNF. Similar effects have been shown in previous studies on cellulose-amino
acid copolymers [28,29]. Altogether, the analysis of the solid-state NMR spectra indicated
the presence of covalently bound cysteine in cys-CNF and the formation of its oxidized
dimer cystine.
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The cysteine-functionalization of CNF was further investigated by elemental anal-
ysis, confirming and quantifying the presence of cysteine in the modified CNF material.
Elemental analysis indicated that increasing the molar ratio in the reaction did not result
in a significant increase in the number of incorporated cysteine (Table 1), obtaining a
substitution between 50–60% of the carboxyl groups in the starting material. The cys-CNF
material was also analyzed by scanning electron microscopy (SEM) with energy dispersive
spectroscopy (EDS), revealing a homogeneous distribution of sulfur on the material surface
(Figure S1, S pplementary Materials).
Table 1. Cysteine content, degree of substitution, and free-thiol content of the cys-CNF materials









(m ol/g CNF) 4
Thiol/Sulfur
(%)
1:6 0.71 0.07 0. 0.05 0.14 0.02 20
1:20 0.78 0.04 0. 0.05 0.20 0.03 26
1 CO H:cystein . 2 Determined by elem ntal analysis of sulfur content. 3 Number of cysteine (mmol/g CNF) per
number of carboxyl groups in the starting material c-CNF (1.3 mmol/g CNF). 4 Determined by the Ellman assay.
The potential ability of the cys-CNF to modulate the chronic wound environment is
expected to depend on the presence of free thiol groups and therefore the cys-CNF was
further characterized in terms of free thiol content by the Ellman assay. Results showed that
the number of free thiols corresponded to 20–26% of the total sulfur content in cys-CNF
(Table 1). The formation of cystine is most probably the reason behind the decrease in
thiol groups with respect to the total sulfur content. The presence of cystine in cys-CNF
was observed in the NMR spectrum (Figure 2) and the oxidized dimer could have formed
during the synthesis step where free cysteines reacted with already immobilized cysteine
molecules or during the dialysis steps as a result of the reaction between neighboring
immobilized cysteines forming disulfide bonds.
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3.2. Radical Scavenging Activity
High levels of ROS in chronic wounds have been associated with several adverse
effects (e.g., cell damage, inhibition of cell migration, inactivation of metalloproteinase
inhibitors, and recruitment of more inflammatory cells into the wound), all contributing to
the delayed healing process [30]. Thus, wound dressings with antioxidant properties may
modulate the ROS levels in the wound bed and help to reactivate the healing of chronic
wounds [31,32].
The antioxidant activity of cysteine is well documented, both in proteins and as free
amino acid [25]. Authors have shown that cysteine is one of the most potent antioxidant
amino acids, acting as a free radical scavenger and also as a metal chelator [25]. Here, the
results indicated that the covalently bound cysteine endowed CNF with radical scavenging
activity, with the functionalized CNF material showing a concentration-dependent DPPH
inhibition (Figure 3a) while c-CNF did not inhibit DPPH radical activity (data not shown).
No statistically significant differences were found between the radical scavenging activities
of cys-CNF (1:6) and cys-CNF (1:20).
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The antioxidant properti s of cellulose-based wound dressings have b en previously
investigated [33–37]. The ability of the commercially available carboxymethylcellulose-
based dressing Aquacel™ to inhibit ROS activity was investigated by Moseley et al.,
showing tha the dressing present d an tiox dant poten ial most probably based on the
restric ion f the movement of the free radical (i.e., the ROS molecules can be entrapped into
the viscous mesh-network of the dressing) and as a result, th y are not abl t interact with
biological tar ets [33,34]. Thus, the antioxidant properties of th carboxymeth lcellulos -
based dre sing can be lassified as passive, rath r than an i tri sic a t oxidant capacity
of the mat rial. Moreover, when Cullen et al. tested he antioxidant pro erti s of car-
boxymethylcellulose with e DDPH ass y, no activity was found confirming the lack of
intrinsic antioxidant activity of the carboxymethylated cellulose [37], a result that is in line
with our finding that c-CNF alone lacks free radical scavenging activity. Here, we showed
that the covalent functionalization of the cellulose nanofibers with cysteine is a promis-
ing approach to obtain a nanocellulose-based dressing capable of directly reacting with
free radicals. Another strategy to endow nanocellulose-based dressings with antioxidant
properties is to incorporate antioxidant compounds within the fiber matrix, allowing the
dressing to act as a drug delivery system [35,36]. This approach presents the challenge
of tailoring the drug load and release, while with a cys-CNF based wound dressing, the
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antioxidant capacity may be easier to control, since the antioxidant properties originate
from the dressing matrix itself.
3.3. Interactions with the Metalloprotease Collagenase
The elevated activity of metalloproteinases found in chronic wounds causes excessive
extra cellular matrix degradation, alteration of cytokine profile, and low levels of growth
factors, resulting in the delay or absence of wound closure [22,38]. Several therapies based
on the inhibition of metalloproteinase activity have been proposed as promising strategies
to treat chronic wounds [22].
We selected collagenase as model metalloproteinase to investigate cys-CNF interac-
tions with this type of proteases. Collagenase incubation with cys-CNF for 24 h resulted in
dose-dependent inhibition of the protease activity, reaching total inhibition when the mate-
rial was assessed at the highest concentration (Figure 3b). To investigate the contribution of
protein entrapment within the nanofiber network to the observed decrease in collagenase
activity, protein concentration was evaluated after incubating the collagenase with cys-CNF
for 24 h. Results showed no protein entrapment with the lowest amount of cys-CNF and
only 20–30% of the collagenase was retained when the highest amount of cys-CNF was
assessed (Table 2). Thus, the main reason behind the observed decrease in collagenase
activity is most probably the protease inactivation rather than just the entrapment of the
protein within the fibril network. In this sense, it should also be noted that CNF alone
(i.e., c-CNF) did not affect the activity of collagenase (Figure S2, Supplementary Materials).
Table 2. Entrapment of collagenase after incubation with the cys-CNF suspension (3.5 mg dry content).
Cys-CNF Sample Collagenase Entrapment(% of Control)
(1:6) 20 ± 5
(1:20) 30 ± 5
It is expected that the sequestration of Zn2+ ions from the metalloproteinase active site
would result in the inhibition of the protease activity [39]. Thus, the Zn2+-chelating capacity
of cysteine [40] is most probably responsible for the observed decrease in collagenase
activity after incubation with cys-CNF. Results of the Zn2+ binding assay showed that
cys-CNF was able to bind 66 ± 1% of the Zn2+ present in a solution incubated with the
material in the same conditions as in the collagenase interaction study, while no ion binding
was detected with c-CNF. Even though the material interaction with free zinc in solution
cannot be directly compared with the access to zinc in a protein’s catalytic center, the above
results showed that cysteine did not lose its zinc binding capacity when incorporated into
the CNF material.
3.4. Material Stability over Time
The instability of thiol-containing compounds toward self-oxidation in the presence of
molecular oxygen is well known [41,42] and it could present a challenge for the bioactivity
of the cys-CNF material. Even though the complete mechanism is yet to be established, self-
oxidation of thiols by molecular oxygen seems to be dependent on pH and on the presence
of transition metals that catalyze the reaction (i.e., present due to impurities) [41,42].
The thiol group content of cys-CNF and its radical scavenging activity were evaluated
over a 30 day period. Results showed that when cys-CNF was stored as a gel suspension
in close containers at 4 ◦C, the thiol content decreased over time, showing 40–50% of the
initial value 30 days after synthesis (Figure 4A). Even though the capacity of cys-CNF to
inhibit the DPPH radical also decreased overtime, the observed loss in radical scavenging
activity was less marked than the decrease in thiol content, with the remaining activity
after 30 days representing 70% of the initial value (Figure 4B).
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Two other storage conditions were evaluated in order to increase the thiol stability
over time. To reduce the mobility of the fibers and thus hinder thiol-to-thiol encounters to
form disulfide bonds, aerogels were prepared by freeze-drying the cys-CNF suspensions.
Additionally, the cys-CNF suspensions were kept under an inert atmosphere to reduce
the oxidation rate of the thiol groups. Both cys-CNF aerogels and the cys-CNF in inert
atmosphere were more stable than the material stored in suspension (Table 3). Even though
the reactivity of the thiol group poses a challenge to the shelf life of cys-CNF, alternative
storage conditions such as inert atmosphere or aerogel form are valid approaches to increase
the stability of the thiol groups in the cys-CNF material.
Table 3. Remaining thiol content (%) in cys-CNF after 30 days of storage at different conditions.
Cys-CNF Sample Suspension(Air) Aerogel
Inert
Atmosphere (N2)
(1:6) 49 ± 13 67 ± 19 105 ± 4
(1:20) 43 ± 8 89 ± 11 76 ± 4
3.5. Cell Studies
If intend d to be used a a wound dressing, the safety profile of the thiol-functionalized
CNF should be assessed. As a first screening, hDF, a well-established model system to
study fibroblast response and wound healing, were selected to evaluate the in vitro toxicity
of the cys-CNF material. The cytotoxic effects of cys-CNF (1:20) and c-CNF were evaluated
by investigating the effect on cell metabolic activity and by microscopic evaluation of cell
viability and morphology after exposure to the materials. Results showed that after 24 h ex-
posure to the CNF materials (concentration range 0.1–1 mg/mL), the cell metabolic activity
was above the 70% cytotoxicity limit described by the ISO standard 10993-5 [43] (Figure 5).
However, the highest concentration of cys-CNF induced a statistically significant decrease
in cell metabolic activity compared with the negative control. Microscopy observations
showed that the number of viable cells after exposure to the materials was comparable to
the number of cells present in the negative control (non-exposed cells). Furthermore, the
cell morphology was not affected by the exposure to increasing concentrations of cys-CNF
or c-CNF, with cells maintaining the characteristic elongated shape of fibroblast cells in
contrast with the round-shaped cells found in the positive control (Figure 6).
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Overall, cys-CNF did not induce toxic effects on hDF when tested at a concentration up
to 0.5 mg/mL, nor did the starting material c-CNF. These results confirm the safety profile
of nanocellulose fibers when in contact with biological systems, as previously investigated
with different functionalized CNF materials and diverse cell models [44–47]. Future studies
should investigate the in vitro wound healing capacity of cys-CNF in terms of dermal and
epidermal cell response (proliferation, migration, and differentiation).
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4. Conclusions
In the present study, we showed that, by a well-known chemical approach, the amino
acid cysteine was covalently incorporated into CNF endowing CNF with bioactivity toward
the modulation of the chronic wound environment. The cys-CNF material presented a
dual action in vitro: inhibition of metalloproteinase and radical scavenging activity, which
are expected to contribute to the restitution of physiological conditions in the wound bed
and promote the resolution of hard-to-heal wounds.
Supplementary Materials: The following are available online at https://www.mdpi.com/2073-436
0/13/2/249/s1, Figure S1. (A) Representative SEM image of cys-CNF film with (B) its corresponding
scanning of sulfur by SEM-EDS. Scale bar 1 µm; Figure S2. Collagenase assay kinetics. Representative
data of the collagenase activity after incubation with cys-CNF and c-CNF. Control refers to collagenase
incubated without CNF materials.
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